Overview
Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia
Status:
Completed
Completed
Trial end date:
2015-05-01
2015-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to provide SPD422 to subjects who completed Study SPD422 308 and, in the opinion of the Investigator, will continue to benefit from treatment.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
ShireTreatments:
Anagrelide
Criteria
Inclusion Criteria:- Subjects must have completed Study SPD422 308